Avatar photo

News

CytokineticsAficamten Shows Promise in HCM Treatment

New data on Cytokinetics' aficamten, presented at the European Society of Cardiology Congress 2025, demonstrates its superiority over metoprolol in treating hypertrophic cardiomyopathy (HCM). Findings show improved cardiac structure and function, with a low incidence of atrial fibrillation. The FDA is reviewing aficamten's application.

Texas Monthly‘s Docuseries Returns to PBS

Texas Monthly Presents, a docuseries showcasing Texas Monthly's storytelling, returns to Texas PBS stations with 13 new episodes. The series explores diverse Texas themes, building on the success of its initial four-episode run. Viewers can watch on Sundays at 6 p.m. CT or stream online.

Alnylam‘s Vutrisiran Shows Long-Term Cardiac Benefits

New data from the HELIOS-B Phase 3 trial show Alnylam's AMVUTTRA (vutrisiran) provides sustained cardiovascular benefits in patients with ATTR-CM for up to 48 months. This includes a significant reduction in mortality and cardiovascular events. The findings reinforce vutrisiran's potential as a first-line treatment.

Synkka secures funding to drive automation in parcel delivery

London-based LogisticsTech startup Synkka has raised a pre-Seed round to accelerate the rollout of its AI-powered workforce and reduce parcel delivery costs. Strategic backing from industry insiders Synkka, founded in 2024, confirmed the completion of an oversubscribed pre-Seed investment led…

Temu Launches Local Seller Program in Turkey, Begins Hiring Spree

Global e-commerce platform Temu is launching its “local-to-local” initiative in Turkey, opening its marketplace to local vendors and actively recruiting for its Istanbul office. Temu, the rapidly growing online marketplace owned by PDD Holdings, is significantly deepening its operational footprint…